COVID-19 Treatments

The locations displayed have either self-attested they have inventory of Paxlovid (nirmatrelvir packaged with ritonavir), Lagevrio (molnupiravir), or Veklury (Remdesivir) within at least the last two months and/or reported participation in the Paxlovid Patient Assistance Program. Sites that have not reported in the last two weeks display a notification, "Inventory has not been reported in the last 2 weeks. Please contact the provider to make sure the product is available." Outpatient COVID-19 medications may be available at additional locations not listed on this website.

All therapeutics identified in the locator not approved by the FDA must be used in alignment with the terms of the respective product’s Emergency Use Authorization. Visit COVID-19 Treatments and Therapeutics for more information on all treatment options. This website identifies sites that have commercially purchased inventory of COVID-19 treatments and, in some cases, may identify sites that have remaining, no-cost U.S. government distributed supply.

Some sites may charge for services not covered by insurance. Some sites may offer telehealth services. This website is intended for informational purposes only and does not serve as an endorsement or recommendation for use of any of the locations listed on the sites.

Clarification for DoD Facilities: Those individuals eligible for care in an MTF include Active Duty Service Members (ADSMs), covered beneficiaries enrolled in TRICARE Prime or Select, including TRICARE Reserve Select (TRS), TRICARE Retired Reserve (TRR) and TRICARE Young Adult (TYA) participants, TRICARE for Life beneficiaries, and individuals otherwise entitled by law to MTF care (e.g., regular retired members and their dependents who are not enrolled in TRICARE but who are otherwise eligible for MTF space-available care, certain foreign military members and their families registered in DEERS, and others).